You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

LOVAZA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Lovaza patents expire, and when can generic versions of Lovaza launch?

Lovaza is a drug marketed by Woodward and is included in one NDA.

The generic ingredient in LOVAZA is omega-3-acid ethyl esters. There are thirteen drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the omega-3-acid ethyl esters profile page.

Drug patent expirations by year for LOVAZA
Drug Prices for LOVAZA

See drug prices for LOVAZA

Drug Sales Revenue Trends for LOVAZA

See drug sales revenues for LOVAZA

Recent Clinical Trials for LOVAZA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Prisma Health-MidlandsPhase 2/Phase 3
H. Lee Moffitt Cancer Center and Research InstitutePhase 2
James and Esther King Biomedical Research ProgramPhase 2

See all LOVAZA clinical trials

Paragraph IV (Patent) Challenges for LOVAZA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
LOVAZA Capsules omega-3-acid ethyl esters 1 g 021654 3 2008-11-10

US Patents and Regulatory Information for LOVAZA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Woodward LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for LOVAZA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Woodward LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ⤷  Try a Trial ⤷  Try a Trial
Woodward LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ⤷  Try a Trial ⤷  Try a Trial
Woodward LOVAZA omega-3-acid ethyl esters CAPSULE;ORAL 021654-001 Nov 10, 2004 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for LOVAZA

See the table below for patents covering LOVAZA around the world.

Country Patent Number Title Estimated Expiration
Japan 2810916 ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 2004007655 ⤷  Try a Trial
Israel 91275 Fatty acid composition containing a mixture of (all-Z)-5, 8, 11, 14, 17-eicosapentaenoic acid and (all-Z)-4, 7, 10, 13, 16, 19-docosahexaenoic acid for treatment and prophylaxis of multiple risk factors for cardiovascular diseases ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.